These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8067036)

  • 41. [Blood insulin and arterial pressure in patients with chronic uremia in hemodialysis].
    Calzavara P; Vianello A; Gatti PL; Da Porto A; Teodori T; Calconi G
    G Clin Med; 1987 Nov; 68(11):567-8. PubMed ID: 3329131
    [No Abstract]   [Full Text] [Related]  

  • 42. Plasma renin activity and blood pressure in terminal renal failure.
    Weidmann P; Maxwell MH; Lupu AN; Lewin AJ; Massry SG
    N Engl J Med; 1971 Sep; 285(14):757-62. PubMed ID: 5567260
    [No Abstract]   [Full Text] [Related]  

  • 43. [A computer program for the drug dosage of patients with chronic kidney failure].
    Krivoshiev S; Kalaĭdzhiev Zh; Antonov S; Zlatarska S; Kiriakov Z
    Khirurgiia (Sofiia); 1989; 42(5):108-10. PubMed ID: 2625912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Heinz body formation and abnormal methemoglobin reduction. Expressions of damage to erythrocytes in chronic kidney failure].
    Grieger M; Rapoport S
    Haematologia (Budap); 1976; 10(2):157-68. PubMed ID: 1030681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The influence of l-histidine substitution on protein metabolism (transferrin and complement system) and renal anaemia in endstage renal failure (author's transl)].
    Kult J; Röckel A; Hennemann H; Heidland A
    Med Klin; 1974 Nov; 69(45):1845-9. PubMed ID: 4444649
    [No Abstract]   [Full Text] [Related]  

  • 46. [The effect of recombinant human erythropoietin during hemodialysis on the thrombocyte and erythrocyte functions of patients with chronic kidney failure].
    Rud'ko IA; Balashova TS; Kubatiev AA; Ermolenko VM
    Ter Arkh; 1994; 66(6):57-60. PubMed ID: 7940371
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Use of lactulose in the treatment of chronic renal failure].
    Quarto di Palo F; Buccianti G; Civardi F
    Minerva Med; 1978 Feb; 69(7):455-60. PubMed ID: 634497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Effect of the passage of blood through the dialyzer on the plasma content of growth hormone and insulin].
    Czekalski S; Baczyk K
    Proc Eur Dial Transplant Assoc; 1972; 9():97-107. PubMed ID: 4668956
    [No Abstract]   [Full Text] [Related]  

  • 49. Efficacy and tolerance of treatment with recombinant-human erythropoietin in chronic renal failure (pre-dialysis) patients.
    Frenken LA; Verberckmoes R; Michielsen P; Koene RA
    Nephrol Dial Transplant; 1989; 4(9):782-6. PubMed ID: 2516609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The crythrocyte system in terminal renal failure caused by chronic glomerulonephritis, treated by hemodialysis].
    Dobiecka-Wawrzecka B
    Wiad Lek; 1980 Jun; 33(11):849-54. PubMed ID: 7423987
    [No Abstract]   [Full Text] [Related]  

  • 51. [The role of the phenomenon of the redistribution of aminoglycosides in their monitoring and dosage calculation in patients in the terminal stage of kidney failure undergoing systematic hemodialysis treatment].
    Siniukhin VN; Darenkov AF; Stetsiuk EA; Nikolaeva NP; Iarmolinskiĭ IS
    Urol Nefrol (Mosk); 1991; (1):43-7. PubMed ID: 1858206
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Thiamine penetration into erythrocytes of patients with chronic renal failure treated with repeated dialyses].
    Kopczyński Z; Chmiel J; Baczyk K; Czarnecki R
    Pol Tyg Lek; 1982 Mar; 37(1):13-5. PubMed ID: 7111064
    [No Abstract]   [Full Text] [Related]  

  • 53. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
    Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
    Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insulin therapy in renal disease.
    Iglesias P; Díez JJ
    Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dialysis: the sweetness of glitazones: randomized trials needed.
    Zoccali C
    Nat Rev Nephrol; 2009 Sep; 5(9):497-8. PubMed ID: 19701227
    [No Abstract]   [Full Text] [Related]  

  • 57. [The insulin therapy of patients with terminal chronic kidney failure].
    Tychka IB; Petrykiv AV
    Lik Sprava; 1994 Jan; (1):96-9. PubMed ID: 8067036
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.